Description
Description
Objectives :
1. Reis olatio n of a virulent strain – in vivo passage of Mmm strain Afade (ILRI)
2. Development of a novel challenge model using a nebulizer fitted with a mask (ILRI and KALRO)
3. Process development and production of a scalable vaccine antigen production (KALRO, MERCK, VIDO)
4. On-Station Efficacy Trial (KALRO)
5. Tr a n s m i s s i o n t r i a l ( K A L R O )
Comments
Add new comment